Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    granules-india-limited-m-2025-07-07

    Virtual Booth

    Contact Supplier

    Allsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Vestronidase Alfa

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 6Mepsevii

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Mepsevii

    Vestronidase alfa

    arrow
    Pharmex
    Not Confirmed

    Brand Name : Mepsevii

    U.S.A
    arrow
    Pharmex
    Not Confirmed

    Ultragenyx Pharm Inc

    Vestronidase alfa

    Main Therapeutic Indication : Genetic Disorders

    Currency : USD

    2019 Revenue in Millions : 13

    2018 Revenue in Millions : 8

    Growth (%) : 60

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Mepsevii

    Vestronidase alfa

    arrow
    Pharmex
    Not Confirmed

    Brand Name : Mepsevii

    U.S.A
    arrow
    Pharmex
    Not Confirmed

    Ultragenyx Pharm Inc

    Vestronidase alfa

    Main Therapeutic Indication : Genetic Disorders

    Currency : USD

    2020 Revenue in Millions : 15

    2019 Revenue in Millions : 13

    Growth (%) : 21

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Mepsevii

    Vestronidase alfa

    arrow
    Pharmex
    Not Confirmed

    Brand Name : Mepsevii

    U.S.A
    arrow
    Pharmex
    Not Confirmed

    Ultragenyx Pharm Inc

    Vestronidase alfa

    Main Therapeutic Indication : Genetic Disorders

    Currency : USD

    2021 Revenue in Millions : 16

    2020 Revenue in Millions : 15

    Growth (%) : 5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Mepsevii

    Vestronidase Alfa

    arrow
    Pharmex
    Not Confirmed

    Brand Name : Mepsevii

    U.S.A
    arrow
    Pharmex
    Not Confirmed

    Ultragenyx Pharm Inc

    Vestronidase Alfa

    Main Therapeutic Indication : Rare Diseases

    Currency : USD

    2022 Revenue in Millions : 21

    2021 Revenue in Millions : 16

    Growth (%) : 29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Mepsevii

    Vestronidase Alfa

    arrow
    Pharmex
    Not Confirmed

    Brand Name : Mepsevii

    U.S.A
    arrow
    Pharmex
    Not Confirmed

    Ultragenyx Pharm Inc

    Vestronidase Alfa

    Main Therapeutic Indication : Rare Diseases

    Currency : USD

    2023 Revenue in Millions : 30

    2022 Revenue in Millions : 21

    Growth (%) : 48

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Mepsevii

    Vestronidase Alfa

    arrow
    Pharmex
    Not Confirmed

    Brand Name : Mepsevii

    U.S.A
    arrow
    Pharmex
    Not Confirmed

    Ultragenyx Pharm Inc

    Vestronidase Alfa

    Main Therapeutic Indication : Rare Diseases and Disorders

    Currency : USD

    2024 Revenue in Millions : 30

    2023 Revenue in Millions : 30

    Growth (%) : 0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF